HighTower Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,000
Closed -$576 3809
2024
Q1
$576 Sell
1,000
-4,000
-80% -$29.6K ﹤0.01% 3540
2023
Q4
$8.01K Buy
5,000
+4,980
+24,900% +$35.8K ﹤0.01% 3451
2023
Q3
$4.17K Sell
20
-50
-71% -$217 ﹤0.01% 3432
2023
Q2
$14.1K Buy
+70
New +$155 ﹤0.01% 3278
2021
Q2
Sell
-50
Closed -$9K 3282
2021
Q1
$9K Buy
+50
New +$900 ﹤0.01% 2933

Other funds holding LFMD

HighTower Advisors's LFMD Position: Q4 2024 in Review

HighTower Advisors sold out of LifeMD (LFMD) in Q4 2024, closing a stake of 27,591 shares — an estimated $145K sold.

HighTower Advisors first reported a position in LFMD in Q4 2020 and held it in 16 quarters. The position peaked at $1.56M in Q1 2021. 106 funds tracked by Wall St. Rank hold LFMD as of Q4 2024.

  • HighTower Advisors reported no remaining LifeMD position as of Q4 2024 after selling out during the quarter.
  • HighTower Advisors sold 27,591 LifeMD shares in Q4 2024, an estimated $145K.
  • HighTower Advisors first reported a position in LifeMD in Q4 2020 and held it in 16 quarters.
  • HighTower Advisors's LifeMD position peaked at $1.56M in Q1 2021.
  • 106 funds tracked by Wall St. Rank held LifeMD as of Q4 2024.

Based on HighTower Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.